Adolescent chronic apomorphine treatment impairs latent inhibition and reduces prefrontal cortex mGluR5 receptor expression in adult rats

European Journal of Pharmacology

Volumn 649, Issue 1-3, 2010, Pages 202-205

  Shao, Feng ^a   Han, Xiao ^a   Li, Nanxin ^a,b   Wang, Weiwen ^c  

^a PEKING UNIVERSITY   (China)

^b YALE UNIVERSITY   (United States)

^c INSTITUTE OF PSYCHOLOGY   (China)

Author keywords

Adolescent; Apomorphine; Dopamine; Glutamate; Latent inhibition; Schizophrenia

Indexed keywords

APOMORPHINE; METABOTROPIC RECEPTOR 5;

ADOLESCENCE; ADOLESCENT; ADULTHOOD; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; LATENT INHIBITION; LATENT PERIOD; LONG TERM EXPOSURE; MALE; NERVE CELL DIFFERENTIATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STIMULUS RESPONSE; WESTERN BLOTTING;

ANIMALS; APOMORPHINE; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DOPAMINE AGONISTS; DOWN-REGULATION; MALE; NERVE TISSUE PROTEINS; NEURAL INHIBITION; NEURONS; PREFRONTAL CORTEX; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, METABOTROPIC GLUTAMATE; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 78049269006     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.051     Document Type: Article

References (25)

1. Bills C., Schachtman T.R., Serfozo P., Spooren W.P., Gasparini F., Simonyi A. Effects of metabotropic glutamate receptor 5 on latent inhibition in conditioned taste aversion. Behav. Brain Res. 2005, 157:71-78.
2. Braga P.Q., Dias F.R., Carey R.J., Carrera M.P. Behavioral sensitization to dopaminergic inhibitory and stimulatory effects induced by low vs. high dose apomorphine treatments: an unconventional dose and response reversal sensitization challenge test reveals sensitization mechanisms. Behav. Brain Res. 2009, 204:169-174.
3. Broersen L.M., Feldon J., Weiner I. Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion. Neuroscience 1999, 94:39-46.
4. Dias R., Robbins T.W., Roberts A.C. Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behav. Neurosci. 1996, 110:872-886.
5. Ellenbroek B.A., Geyer M.A., Cools A.R. The behavior of APO-SUS rats in animal models with construct validity for schizophrenia. J. Neurosci. 1995, 15:7604-7611.
6. Feldon J., Shofel A., Weiner I. Latent inhibition is unaffected by direct dopamine agonists. Pharmacol. Biochem. Behav. 1991, 38:309-314.
7. Fone K.C., Porkess M.V. Behavioural and neurochemical effects of post-weaning social isolation in rodents - relevance to developmental neuropsychiatric disorders. Neurosci. Biobehav. Rev. 2008, 32:1087-1102.
8. Gosselin G., Oberling P., Di Scala G. Antagonism of amphetamine-induced disruption of latent inhibition by the atypical antipsychotic olanzapine in rats. Behav. Pharmacol. 1996, 7:820-826.
9. Kumari V., Cotter P.A., Mulligan O.F., Checkley S.A., Gray N.S., Hemsley D.R., Thornton J.C., Corr P.J., Toone B.K., Gray J.A. Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers. J. Psychopharmacol. 1999, 13:398-405.
10. Leng A., Ouagazzal A., Feldon J., Higgins G.A. Effect of the 5-HT6 receptor antagonists Ro04-6790 and Ro65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine. Pharmacol. Biochem. Behav. 2003, 75:281-288.
11. Li N., Wu X., Li L. Chronic administration of clozapine alleviates reversal-learning impairment in isolation-reared rats. Behav. Pharmacol. 2007, 18:135-145.
12. Li N., Ping J., Wu R., Wang C., Wu X., Li L. Auditory fear conditioning modulates prepulse inhibition in socially reared rats and isolation-reared rats. Behav. Neurosci. 2008, 122:107-118.
13. Lipina T., Weiss K., Roder J. The ampakine CX546 restores the prepulse inhibition and latent inhibition deficits in mGluR5-deficient mice. Neuropsychopharmacology 2007, 32:745-756.
14. Lubow R.E. Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophr. Bull. 2005, 31:139-153.
15. Lubow R.E., De la Casa L.G. There is a time and a place for everything: bidirectional modulations of latent inhibition by time-induced context differentiation. Psychon. Bull. Rev. 2005, 12:806-821.
16. Masson S., Avanzi V., Troncoso A.C., Brandao M.L. Effects of apomorphine and clozapine on conditioned freezing and latent inhibition. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27:935-943.
17. Melo L.L., Pereira E.C., Pagini C.H., Coimbra N.C., Brandao M.L., Ferrari E.A. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response. Exp. Neurol. 2009, 216:16-21.
18. Salgado J.V., Hetem L.A., Vidal M., Graeff F.G., Danion J.M., Sandner G. Reduction of latent inhibition by d-amphetamine in a conditioned suppression paradigm in humans. Behav. Brain Res. 2000, 117:61-67.
19. Shao F., Jin J., Meng Q., Liu M., Xie X., Lin W., Wang W. Pubertal isolation alters latent inhibition and DA in nucleus accumbens of adult rats. Physiol. Behav. 2009, 98:251-257.
20. Sisk C.L., Zehr J.L. Pubertal hormones organize the adolescent brain and behavior. Front. Neuroendocrinol. 2005, 26:163-174.
21. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000, 24:417-463.
22. Weiner I. Neural substrates of latent inhibition: the switching model. Psychol. Bull. 1990, 108:442-461.
23. Weiner I. The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl.) 2003, 169:257-297.
24. Young A.M., Moran P.M., Joseph M.H. The role of dopamine in conditioning and latent inhibition: what, when, where and how?. Neurosci. Biobehav. Rev. 2005, 29:963-976.
25. Zhao X., Sun L., Jia H., Meng Q., Wu S., Li N., He S. Isolation rearing induces social and emotional function abnormalities and alters glutamate and neurodevelopment-related gene expression in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1173-1177.